Cytoplasmic and nuclear Pak4 showed weak expression in atrophic endometrium and moderate to strong expression in secretory, proliferative, hyperplastic endometrium and endometrial cancers (Fig 3). This evidence concerns the gene PAK4 and endometrial cancer.